The Europe biosimilar market reached USD 13,864 million in 2024 and is projected to hit USD 59,733.3 million by 2033, growing at a CAGR of 17.1% from 2025 to 2033. Growth is driven by supportive reimbursement policies, expanded manufacturing capabilities, and ongoing technological advancements. https://www.imarcgroup.com/europe-biosimilar-market